Trojans develop designs for two potential closures and lay out a transportation plan to support the concept.

The Mark and Mary Stevens Neuroimaging and Informatics Institute’s research will let clinicians evaluate the effectiveness of cell-based therapies used to treat various cancers.

Research will address the neglected role of environmental neurotoxins in the development of Alzheimer’s.

The school announces its full-time MBA Class of 2020 is 52 percent women — a first for top-tier business schools.

After years with no therapies, patients with phenylketonuria, or PKU, now have an available drug and a second is awaiting approval. A USC alumnus and scientist helped make it happen.

Paul Chyz grew up with eclectic interests in science and the guitar. USC helped him bring them together.

International study examines the influence of genetics on human behavior, well-being and social science-related outcomes through details on human genomes.

Rent and other expenses often keep students from pursuing unpaid summer internships. USC Career Center’s Dream Dollars initiative offers much-needed relief.

USC physical therapists work alongside specialists to create individualized treatment.

At the Alzheimer's Association International Conference (AAIC), preliminary results of the A4 Study will be presented by the project director, Dr. Reisa Sperling of Harvard Medical School. Dr. Sperling and Dr. Paul Aisen of the Keck School of Medicine of USC are the principal investigators on the study.